Back
Mineral Resources Vs. Keros Therapeutics Industry Stock Comparison
Sell
8
MALRY
Mineral Resources
Last Price:
23.82
Seasonality Move:
22.18%
Buy
60
KROS
Keros Therapeutics
Last Price:
60.76
Seasonality Move:
38.45%
Sell
8
Mineral Resources (MALRY)
is a Sell
Is Mineral Resources a Buy, Sell or Hold?
- The current Mineral Resources [MALRY] share price is $24.30. The Score for MALRY is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- MALRY is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
60
Keros Therapeutics (KROS)
is a Buy
Is Keros Therapeutics a Buy, Sell or Hold?
- The current Keros Therapeutics [KROS] share price is $60.14. The Score for KROS is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
MALRY Stock Price Chart
What is Mineral Resources's stock price today?
-
The Mineral Resources share price today is $24.30
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MALRY is experiencing selling pressure, which indicates risk of future bearish movement.
KROS Stock Price Chart
What is Keros Therapeutics's stock price today?
-
The Keros Therapeutics share price today is $60.14
The current trend is moderately bullish and KROS is experiencing slight buying pressure.
MALRY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.83 | Sell |
Relative Strength Index (14 RSI): | 37.01 | Sell |
Chaikin Money Flow: | -7159 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (26.08 - 35.72) | Sell |
Bollinger Bands (100): | (26.55 - 39.31) | Sell |
KROS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.25 | Buy |
Relative Strength Index (14 RSI): | 55.64 | Buy |
Chaikin Money Flow: | 82977 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (57.66 - 61.04) | Buy |
Bollinger Bands (100): | (45.18 - 57.08) | Buy |
MALRY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 25.07 | Sell |
20-day SMA: | 30.87 | Sell |
50-day SMA: | 28.5 | Sell |
200-day SMA: | 38.58 | Sell |
8-day EMA: | 25.47 | Sell |
20-day EMA: | 28.18 | Sell |
50-day EMA: | 29.91 | Sell |
200-day EMA: | 36.64 | Sell |
KROS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 60.01 | Buy |
20-day SMA: | 60.01 | Buy |
50-day SMA: | 55.19 | Buy |
200-day SMA: | 54.89 | Buy |
8-day EMA: | 60.09 | Buy |
20-day EMA: | 59.3 | Buy |
50-day EMA: | 56.32 | Buy |
200-day EMA: | 51.82 | Buy |
Mineral Resources Earnings Growth & MALRY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Keros Therapeutics Earnings Growth & KROS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.28 per share, and a decrease next year of $0.49 per share.
Mineral Resources Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Keros Therapeutics Technical Analysis
Oct 15 | Oct 16 | Oct 18 | Oct 21 | Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
15 | 16 | 18 | 21 | 22 | 23 | 24 | 25 | 28 | 29 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |